Haodong Cai

Efficacy and safety of CAR19/22 T-cell cocktail therapy in patients with refractory/relapsed B-cell malignancies

Na Wang, Xuelian Hu, Wenyue Cao et al. · Blood · 2019 · 256 citations · Full text

Tropism-facilitated delivery of CRISPR/Cas9 system with chimeric antigen receptor-extracellular vesicles against B-cell malignancies

Qian Xu, Zheng Zhang, Lei Zhao et al. · Journal of Controlled Release · 2020 · 95 citations

B-cell Malignancies, Crispr/cas9 System, Tropism-facilitated Delivery +8

Safety of telbivudine treatment for chronic hepatitis B for the entire pregnancy

Min Liu, Haodong Cai, Wei Yi · Journal of Viral Hepatitis · 2013 · 54 citations

Preclinical development and evaluation of nanobody-based CD70-specific CAR T cells for the treatment of acute myeloid leukemia

Jiali Cheng, Tong Ge, Xiaojian Zhu et al. · Cancer Immunology Immunotherapy · 2023 · 32 citations · Full text

Telbivudine myopathy in a patient with chronic hepatitis B

Min Wang, Yuwei Da, Haodong Cai et al. · International Journal of Clinical Pharmacy · 2012 · 24 citations

Hepatology, Viral Hepatitis, Telbivudine Myopathy +4